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Abstract
Hypoparathyroidism is genetically heterogeneous and characterized by low plasma calcium 
and parathyroid hormone (PTH) concentrations. X-linked hypoparathyroidism (XLHPT) in 
two American families is associated with interstitial deletion-insertions involving deletions 
of chromosome Xq27.1 downstream of SOX3 and insertions of predominantly non-coding 
DNA from chromosome 2p25.3. These could result in loss, gain, or movement of regulatory 
elements, which include ultraconserved element uc482, which could alter SOX3 expression. 
To investigate this, we analysed SOX3 expression in EBV-transformed lymphoblastoid 
cells from three affected males, three unaffected males, and four carrier females from 
one XLHPT family. SOX3 expression was similar in all individuals, indicating that the 
spatiotemporal effect of the interstitial deletion-insertion on SOX3 expression postulated 
to occur in developing parathyroids did not manifest in lymphoblastoids. Expression of 
SNTG2, which is duplicated and inserted into the X chromosome, and ATP11C, which is 
moved telomerically, were also similarly expressed in all individuals. Investigation of male 
hemizygous (Sox3−/Y and uc482−/Y) and female heterozygous (Sox3+/− and uc482+/−) knockout 
mice, together with wild-type littermates (male Sox3+/Y and uc482+/Y, and female Sox3+/+ 
and uc482+/+), revealed Sox3−/Y, Sox3+/−, uc482−/Y, and uc482+/− mice to have normal plasma 
biochemistry, compared to their respective wild-type littermates. When challenged with a 
low calcium diet, all mice had hypocalcaemia, and elevated plasma PTH concentrations and 
alkaline phosphatase activities, and Sox3−/Y, Sox3+/−, uc482−/Y, and uc482+/− mice had similar 
plasma biochemistry, compared to wild-type littermates. Thus, these results indicate that 
absence of Sox3 or uc482 does not cause hypoparathyroidism and that XLHPT likely reflects 
a more complex mechanism.
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Introduction
Heritable hypoparathyroidism (HPT) is a genetically 
heterogeneous disease, characterized biochemically 
by hypocalcaemia, hyperphosphatemia, low plasma 
parathyroid hormone (PTH) concentrations and 
inappropriately normal or high urinary calcium 
excretion (1). Genetic abnormalities causing HPT may 
lead to complex congenital syndromes or to an isolated 
endocrinopathy, for which autosomal dominant, 
autosomal recessive and X-linked modes of inheritance 
have been described (OMIM #146200 and %307700) (2). 
These genetic abnormalities may result in defects in PTH 
itself, parathyroid gland development, or parathyroid 
gland function. For example, mutations in PTH cause 
a lack of functional PTH protein (3), mutations in 
the parathyroid-specific transcription factor glial cells 
missing B (GCMB) result in defective parathyroid gland 
development (4, 5), and gain-of-function mutations in the 
calcium-sensing receptor (CaSR) may suppress parathyroid 
gland function in association with hypocalcaemia (6).
X-linked HPT (XLHPT, OMIM %307700) was first 
reported in 1960 (7) in a large kindred from Missouri 
(MO), USA and subsequently in a related family also from 
MO (8, 9, 10), and more recently in a third, unrelated 
family from Illinois (IL), USA (11). Both families from 
MO and the family from IL had interstitial deletion-
insertions involving deletion of a non-coding region on 
chromosome Xq27.1 between sex-determining region Y 
(SRY)-box 3 (SOX3) and adenosine triphosphatase 11C 
(ATP11C), and an insertion of a larger section emanating 
from chromosome 2p25.3 (8, 11) (Fig. 1A). In the MO 
kindred, this consisted of a ~25 kb deletion of non-coding 
DNA from Xq27.1 ~67 kb downstream of SOX3 and an 
inverted insertion of ~340 kb containing exons 2–16 of 
syntrophin gamma 2 (SNTG2) from 2p25.3 (8) (Fig. 1A). 
In the IL family, ~1.5 kb was deleted from Xq27.1 ~80 kb 
downstream of SOX3 and ~47 kb of non-coding DNA was 
inserted from 2p25.3, which differed from the inserted 
DNA in the MO kindred (11) (Fig. 1A). Although the 340 
kb insertion in the MO kindred contained 15 exons of 
SNTG2, no open reading frames were present (8), and the 
47 kb insertion in the IL family did not contain coding 
DNA. Similarly, neither of the X chromosome deletions 
removed coding DNA. We therefore hypothesized 
that these rearrangements may alter the function of a 
regulatory element or nearby gene, that affects SOX3 
expression, which has been demonstrated in developing 
mouse parathyroids between embryonic day (E)10.5 and 
E15.5 (8). SOX3 expression was reported to be altered by 
a large 774 kb insertion downstream of SOX3 in patients 
with XX male sex reversal, demonstrating that SOX3 
expression may be susceptible to position effects, similar 
to those reported for SOX9 and SRY (12, 13), although 
SOX3-coding mutations have not been identified in male 
patients with HPT (14).
Thus, in the XLHPT families there are three possible 
mechanisms that could result in such alterations in SOX3 
ATP11C
SOX3
2
16
S
N
TG
2 
ex
on
s 
2-
16
2
16
2p25.3 2p25.3
25kb
deletion 1.5kb
deletion
47kb
insertion
856kb
903kb
340kb
insertion
1290kb
950kb
67kb
80kb
158kb 158kb
308kb 319kb
uc482
ATP11C SOX3
1 2
3
A
B
Xq27.1
Mus
Rattus
Gallus
Xenopus
Takifugu
Danio
SOX3ATP11C
MO family IL family
Xq27.1
S
N
TG
2 
ex
on
s 
2-
16
MIR505
Figure 1
Chromosomal rearrangements associated with XLHPT. (A) Unrelated 
families from Missouri (MO) and Illinois (IL), USA, have interstitial 
deletion-insertions involving chromosome Xq27.1 and chromosome 
2p25.3. In the MO kindred, a 25 kb Xq27.1 deletion is replaced by a ~340 
kb inverted insertion containing exons 2–16 of syntrophin gamma 2 
(SNTG2). In the IL family, a 1.5 kb Xq27.1 deletion is replaced by a 47 kb 
2p25.3 insertion that does not contain any coding DNA. These deletion-
insertions occur downstream of sex-determining region Y (SRY)-box 3 
(SOX3) and upstream of adenosine triphosphatase 11C (ATP11C) and the 
ultraconserved element uc482. uc482 is a genome region conserved from 
human through mouse (Mus), rat (Rattus), chicken (Gallus), frog 
(Xenopus), and puffer fish (Takifugu) to zebrafish (Danio) (plotted using 
Vista Browser). MIR505 (chromosomal location 139,924,148-139,924,231 
(GRCh38/hg38)) is located within the first intron in two of the nine ATP11C 
(chromosomal location 139,726,346-139,945,276 (GRCh38/hg38)) 
transcripts and upstream of the remaining seven transcripts, five of which 
are protein-coding. (B) Three possible mechanisms by which the XLHPT 
deletion-insertions may alter SOX3 expression are (1) loss of an enhancer 
or repressor (represented by box 1) from Xq27.1; (2) gain of an enhancer 
or repressor (represented by box 2) from 2p25.3; or (3) movement of an 
enhancer or repressor (represented by box 3) away from SOX3, as the 
insertion is larger than the deletion.
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expression (Fig. 1B). Firstly, deletions of X chromosome 
sequences may result in loss of a repressor or enhancer 
of SOX3 expression. Secondly, insertions of chromosome 
2 sequences may result in insertion of DNA that may 
repress or enhance SOX3 expression. Thirdly, deletion-
insertions, that result in a net gain of DNA on the X 
chromosome, may move a repressor or enhancer of SOX3 
expression further away from SOX3, thereby altering 
its effect on SOX3 expression, that is, a position effect 
(Fig. 1B). Gene enhancers and repressors are often 
evolutionarily conserved, and >60% of ultraconserved 
(uc) non-coding elements that are conserved in human 
through to Takifugu rubripes (puffer fish), may act as 
positive enhancers (15). One such element, designated 
uc482 (or highly conserved non-coding element (HCNE) 
8), is located ~400 kb downstream of SOX3 and was 
reported to be a likely enhancer of Sox3 expression in 
Danio rerio (zebrafish) (16). Furthermore, uc482 is moved 
further away from SOX3 by both of the deletion-insertions 
causing XLHPT (Fig. 1B).
To explore the possible roles of SOX3 and uc482 in 
HPT, we undertook studies to determine the effects of 
the interstitial deletion-insertion on SOX3 expression 
in patients with XLHPT and in knock-out mice lacking 
alleles of Sox3 and uc482.
Materials and methods
Human studies
Venous blood samples were collected after informed 
consent from individuals and following protocols 
approved by local and national ethics committees (Multi-
centre Research Ethics Committee (London, UK; MREC 
02/2/93) and the Human Research Protections Office, 
Washington University School of Medicine, St. Louis, 
MO, USA).
DNA sequence analysis
DNA was extracted from leukocytes using the Gentra 
Puregene blood kit (Qiagen) and standard protocols. 
PCR amplification of DNA across the deletion-insertion 
boundaries was carried out using primers previously 
described (8), and Sanger DNA sequence analysis 
was performed using the BigDye Terminator v3.1 
Cycle Sequencing Kit (Life Technologies) and an ABI 
automated capillary sequencer (Applied Biosystems), as 
described (4, 8).
Quantitative real-time PCR (qRT-PCR)
Lymphocytes were Epstein-Barr virus (EBV)-transformed 
to generate a lymphoblastoid cell line as previously 
described (3), and mRNA extracted using the Oligotex 
mRNA mini kit (Qiagen) and standard protocols. cDNA 
was generated using Quantiscript reverse transcriptase 
(Qiagen), and quantitative reverse transcriptase 
(qRT)-PCRs performed using the QuantiTect SYBR Green 
PCR kit (Qiagen) in quadruplicate for each individual, and 
SOX3, SNTG2, ATP11C, and GAPDH specific primers, using 
a Rotorgene 5 (Qiagen), as described (17). Expression of 
genes was normalized to GAPDH expression and analyzed 
by the comparative ΔΔCT method (18).
Mouse studies
All animal studies were approved by the University of 
Oxford Ethical Review Committee and were licensed 
(project license numbers PPL 30/2241, PPL 30/2739 and 
PPL 30/3251) under the Animals (Scientific Procedures) 
Act 1986, issued by the UK Government Home Office. 
Sox3-knockout mice were maintained on the MF1 
outbred background (19) and uc482-knockout mice 
were maintained on the C57Bl/6 background (20). Mice 
were genotyped using DNA extracted from ear biopsies 
followed by PCR assay. PCR primers for Sox3 genotyping 
were WT F: 5′-TCGGGTGGTGGGGAAGGGGTTAT-3′, WT 
R: 5′-GTGGGGTGTGCGGCTCAGGTAG-3′, KO F: 5′-CAC 
GGCGAGCCTGTCAATCACGAG-3′, KO R: 5′-TTGATG 
CCGTTCTTTTGCTTGTCG-3′; and for uc482 genotyping 
were For: 5′-GGAAATGAGGCCGAGTCAAG-3′; WT 
R: 5′-TACGAAGACATGTACCTGTGCG-3′; KO R: 5′-TGG 
ACTTGTCAGCTTCTTCCAA-3′. After weaning at age 21 
days, mice were fed either a synthetic control diet (Dyets 
Inc., Bethlehem, PA, USA) containing 0.95% calcium 
and 4.50 iU/g vitamin D3 or a synthetic low-calcium 
diet containing 0.001% calcium and 0.0 iU/g vitamin 
D3 (Dyets Inc.), as previously described (21). The low 
calcium/no vitamin D3 diet has previously been shown 
to unmask defects in the ability of the parathyroid glands 
to respond to deficiencies in dietary calcium, which may 
not be evident when calcium is abundant (21). Food 
and water were allowed ad libitum. Mice were killed and 
blood was collected from the jugular vein for plasma 
analysis using an AU400 clinical chemistry analyser 
(Olympus), and plasma calcium was corrected for albumin 
(Corr. Ca) using the formula: Corr. Ca = Ca (mmol/L) − 
((Alb (g/L) − 30) × 0.017), as described previously (22). 
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PTH concentrations were measured using an ELISA for 
mouse intact PTH (Immutopics, Quidel, San Diego, CA, 
USA), as described previously (22).
Histological studies
To study parathyroids of the knockout mice, the trachea, 
thyroid, and parathyroids were dissected en bloc and 
fixed for 24 h in 10% neutral buffered formalin. Paraffin 
sections (6 µm thickness) were dewaxed and stained with 
haematoxylin and eosin (H&E) using standard techniques. 
H&E stained sections were viewed using an Eclipse E400 
light microscope (Nikon) and images acquired using NIS-
elements BR2.30 imaging software (Nikon). An estimation 
of parathyroid gland size was performed by measuring 
the largest cross-sectional area of the parathyroid gland in 
serial sections from each mouse, as described previously 
(21, 23), and corrected for body weight.
Statistical analyses
For human qRT-PCR analyses, data were analyzed 
using one-way ANOVA, and all data are represented as 
mean ± s.d. fold change relative to unaffected males. 
For animal studies, data were analyzed using unpaired 
Student’s t-test. All data are represented as mean ± s.d., and 
for plasma biochemical results, significances are reported 
after Bonferroni correction for multiple comparisons.
Results
Expression of SOX3, ATP11C and SNTG2 in patients 
with XLHPT
PCR analysis using primers, previously described (8), that 
spanned the telomeric breakpoint, was used to confirm 
the presence or absence of the X chromosome deletion-
insertion in three affected males, four carrier females, 
and three unaffected related males from the MO kindred 
(Fig. 2A). Thus, individuals II.5, II.6 and III.1, who are 
unaffected males with normocalcaemia, were confirmed 
to have only the wild-type (normal) allele; individuals 
IV.1, IV.2 and IV.3, who are affected males with 
hypocalcaemia due to XLHPT, were confirmed to have 
only the mutant allele; and individuals II.2, II.3, II.4 and 
III.2, who are carrier females with normocalcaemia, were 
confirmed to be heterozygous in having wild-type and 
mutant alleles (Fig. 2A). Parathyroid glands from XLHPT 
patients (7), and normal individuals were not available to 
study the expression of SOX3 and ATP11C, which flank 
the interstitial deletion-insertion involving chromosomes 
Xq27.1 and 2p25.3, and the inserted region of SNTG2 
in the XLHPT MO kindred (Fig. 1). Lymphoblastoid cell 
mRNA was therefore used to undertake qRT-PCR analysis 
of SOX3, ATP11C and SNTG2 expression (Fig. 2B). SOX3 
expression (mean ± s.d,) was similar in affected males 
(1.21 ± 1.53-fold) and carrier females (0.85 ± 0.98-fold), 
when compared to unaffected males (1.00 ± 0.68-fold; 
P > 0.8) (Fig. 2B). qRT-PCR analyses of ATP11C, which is 
located downstream of the deletion-insertion, and SNTG2, 
of which exons 2–16 are inserted from chromosome 
2p25.3, revealed no significant differences in expression 
of ATP11C or SNTG2 between affected males (0.80 ± 0.32-
fold and 1.18 ± 0.92-fold, respectively) or carrier females 
(0.91 ± 0.20-fold and 1.11 ± 0.79-fold, respectively), when 
compared to unaffected males (1.00 ± 0.78-fold and 
1.00 ± 0.65-fold; P > 0.8) (Fig. 2B). These results indicated 
that specific spatiotemporal effects of the XLHPT-
associated interstitial deletion-insertions on expression of 
SOX3 or other genes, ATP11C and SNTG2, postulated to 
occur in the developing parathyroids, were not occurring 
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Figure 2
SOX3, SNTG2, and ATP11C expression in XLHPT family members. (A) 
Confirmation of the Xq27.1-2p25.3 deletion-insertion by PCR using 
primers spanning the telomeric breakpoint (Fig. 1) in four carrier females 
(circles with dots), and three affected males (filled squares) from the MO 
kindred. Three unaffected related males (open squares) in whom the 
Xq27.1-2p25.3 insert is not present are also shown. The PCR primers were 
designed to yield a wild-type (WT) product of 237 bp in size, and a mutant 
(M) product of 321 bp in size. S = size marker. (B) Quantitative reverse 
transcriptase (qRT)-PCR analyses of SOX3, ATP11C, and SNTG2 expression 
using mRNA obtained from EBV-lymphoblastoids from unaffected males 
(unaff) (n = 3), affected males (aff) (n = 3) and carrier females (carriers) 
(n = 4), (n = 4 replicates for each individual). Data are displayed as 
mean + s.d. relative to expression in unaffected males.
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in lymphoblastoid cells, which are not representative of 
parathyroid cells. We therefore studied mouse knockout 
models deleted for Sox3 and uc482.
Mice deleted for Sox3 have normal plasma calcium 
and PTH concentrations
Mice were genotyped (Fig. 3A), and wild-type (Sox3+/Y) 
and hemizygous (Sox3−/Y) male adult mice, and wild-
type (Sox3+/+) and heterozygous (Sox3+/−) female adult 
mice were found to have normal body weights and 
plasma biochemistry at ages 6 and 28 weeks (Table 1). 
Thus, corrected calcium concentrations in plasma 
were similar in: Sox3+/Y mice compared to Sox3-/Y mice 
(3.08 ± 0.11 mmol/L vs 3.05 ± 0.15 mmol/L at 6 weeks, and 
2.83 ± 0.19 mmol/L vs 2.79 ± 0.12 mmol/L at 28 weeks, 
n = 10–21); and in Sox3+/+ mice compared to Sox3+/– mice 
(3.02 ± 0.08 mmol/L vs 3.06 ± 0.10 mmol/L at 6 weeks, 
and 2.65 ± 0.12 mmol/L vs 2.73 ± 0.11 mmol/L at 28 weeks, 
n = 9–25). Plasma PTH concentrations were also similar 
in: Sox3+/Y and Sox3−/Y mice (11.8 ± 7.6 pmol/L vs 
12.8 ± 10.4 pmol/L at 6 weeks, and 41.8 ± 31.4 pmol/L vs 
Figure 3
Plasma biochemistry and parathyroid gland sizes 
in wild-type and mutant Sox3 mice consuming 
either control or low calcium and vitamin D diets. 
(A) Genotyping of wild-type (Sox3+/Y) and 
hemizygous (Sox3−/Y) male, and wild-type (Sox3+/+) 
and heterozygous (Sox3+/−) female mice. S: size 
marker; B: blank; WT: wild-type band; mut: 
mutant band. (B) Plasma corrected calcium;  
(C) plasma PTH; (D) plasma alkaline phosphatase 
(ALP) activity; (E) plasma urea; (F) plasma 
creatinine; (G) parathyroid gland area. Wild-type 
males (+/Y) and mutant males (−/Y) are shown by 
the dark grey and light grey solid bars, 
respectively. Wild-type females (+/+) and mutant 
carrier females (+/−) are shown by the dark grey 
and light grey hatched bars, respectively. Data 
are displayed as mean ± s.d. *P < 0.05; **P < 0.01; 
$P < 0.001; $$P < 0.0001 for mice on the low 
calcium and vitamin D (low Ca2+ and vit D) diet 
compared to mice of the same genotype on the 
normal diet. (H) Representative histological 
images used for quantification of parathyroid 
gland area. Pt: parathyroid; Th: thyroid; SM: strap 
muscle. Scale bars = 200 µm.
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35.9 ± 34.1 pmol/L at 28 weeks, n = 14–22); and in Sox3+/+ 
and Sox3+/− mice (15.3 ± 11.8 pmol/L vs 9.9 ± 10.6 pmol/L 
at 6 weeks, and 35.6 ± 23.8 pmol/L vs 24.8 ± 19.1 pmol/L 
at 28 weeks, n = 12–24) (Table 1). In addition, the plasma 
phosphate, urea, creatinine and albumin concentrations, 
and alkaline phosphatase activity were similar in wild-type 
and mutant Sox3 mice at 6 and 28 weeks of age (Table 1).
The standard control mouse chow contains 0.95% 
calcium and 4.5 iU/g vitamin D3, which represent levels 
that are ~150-fold and ~30-fold higher, respectively, than 
those recommended for daily intake in humans (21). 
Furthermore, these high dietary contents of calcium and 
vitamin D have been reported to mask hypocalcaemia 
in mice with a different cause of HPT (21). We therefore 
challenged Sox3+/Y, Sox3−/Y, Sox3+/+, and Sox3+/− mice with 
a diet low in calcium (0.001%) and lacking in vitamin D3 
(low diet) from weaning until 60 days old. Wild-type male 
and female mice on the low diet had significantly lower 
plasma corrected calcium concentrations than those on 
the control diet (mean ± s.d.) (low diet versus control diet 
for Sox3+/Y = 1.96 ± 0.24 mmol/L vs 3.08 ± 0.11 mmol/L, 
P < 0.001; and Sox3+/+ = 2.01 ± 0.26 mmol/L vs 
3.02 ± 0.08 mmol/L, P < 0.001, n = 16–25) (Fig. 3B). These 
lower plasma corrected calcium concentrations, were not 
due to lower plasma albumin concentrations when on the 
low diets, as these plasma albumin concentrations were 
similar (Sox3+/+ = 32.70 ± 0.35 g/L, Sox3+/− = 32.58 ± 0.24 g/L, 
Sox3+/Y = 31.50 ± 0.34 g/L and Sox3−/Y = 32.40 ± 0.40 g/L), 
on low diet to those observed in mice on the control 
diet (Table 1). This hypocalcaemia was associated with 
significant increases in plasma PTH concentrations 
(Sox3+/Y = 150.1 ± 46.3 pmol/L vs 11.8 ± 7.6 pmol/L, P < 0.001; 
and Sox3+/+ = 157.8 ± 47.6 pmol/l vs 15.3 ± 11.8 pmol/L, 
P < 0.001, n = 15–24) (Fig. 3C) and alkaline phosphatase 
(ALP) activities (Sox3+/Y = 668.1 ± 161.9 U/L vs 
258.7 ± 47.2 U/L, P < 0.001; Sox3+/+ = 820.8 ± 234.4 U/L 
vs 296.5 ± 58.4 U/L, P < 0.001, n = 16–25) (Fig. 3D). Wild-
type mice on the low diet, compared to those on the 
control diet, also had significantly lower plasma urea 
concentrations (Sox3+/Y = 5.98 ± 0.91 mmol/L vs 7.85 ± 1.24 
mmol/L, P < 0.001; and Sox3+/+ = 5.69 ± 0.99 mmol/L vs 
6.90 ± 1.13 mmol/L, P = 0.042, n = 18–25) (Fig. 3E) and 
creatinine concentrations (Sox3+/Y = 14.3 ± 0.4 µmol/L vs 
17.3 ± 0.8 µmol/L, P < 0.001; and Sox3+/+ = 14.9 ± 1.11 µmol/L 
vs 17.7 ± 0.9 µmol/L, P < 0.001, n = 17–23) (Fig. 3F).
Similar to wild-type mice, mutant male (Sox3−/Y) and 
heterozygote female (Sox3+/−) mice on the low diet also 
had significantly lower plasma corrected calcium 
concentrations than those on the control 
diet (Sox3−/Y = 1.93 ± 0.20 mmol/L vs 3.05 ± 0.15 mmol/L, 
P < 0.001; and Sox3+/− = 1.91 ± 0.14 mmol/L vs 
3.06 ± 0.10 mmol/L, P < 0.001, n = 13–24) (Fig. 3B). This 
was associated with significantly higher plasma: PTH 
concentrations (Sox3−/Y = 162.6 ± 37.6 pmol/L vs 12.8 ± 10.4 
pmol/L, P < 0.001; and Sox3+/− = 187.5 ± 28.6 pmol/L vs 
9.9 ± 10.6 pmol/L, P < 0.001, n = 13–21) (Fig. 3C); and ALP 
Table 1 Plasma biochemistry in 6- and 28-week-old wild-type and mutant Sox3 mice consuming the control diet.
Genotype
Males Females
Sox3+/Y Sox3−/Y Sox3+/+ Sox3+/−
Age: 6 weeks (n = 19–22) (n = 14–18) (n = 23–25) (n = 12–15)
 Body weight (g) 11.85 ± 3.49 11.74 ± 3.70 12.05 ± 2.30 12.12 ± 2.71
 Corr. Ca (mmol/L) 3.08 ± 0.11 3.05 ± 0.15 3.02 ± 0.08 3.06 ± 0.10
 PTH (pmol/L) 11.8 ± 7.6 12.8 ± 10.4 15.3 ± 11.8 9.9 ± 10.6
 Phosphate (mmol/L) 4.24 ± 0.76 4.10 ± 0.68 4.07 ± 0.62 3.88 ± 0.83
 ALP (U/L) 258.7 ± 47.2 270.2 ± 49.4 296.5 ± 58.4 282.4 ± 48.4
 Urea (mmol/L) 7.85 ± 1.24 7.83 ± 0.87 6.90 ± 1.13 7.10 ± 0.74
 Creatinine (µmol/L) 17.3 ± 0.8 16.8 ± 1.3 17.7 ± 0.9 17.7 ± 1.6
 Albumin (g/L) 30.5 ± 1.7 31.6 ± 2.7 31.7 ± 2.0 32.3 ± 1.7
Age: 28 weeks (n = 10–14) (n = 15–19) (n = 8–12) (n = 14–18)
 Body weight (g) 47.51 ± 6.81 50.17 ± 9.23 32.16 ± 1.66 40.93 ± 8.92
 Corr. Ca (mmol/L) 2.83 ± 0.19 2.79 ± 0.12 2.65 ± 0.12 2.73 ± 0.11
 PTH (pmol/L) 41.8 ± 31.4 35.9 ± 34.1 35.6 ± 23.8 24.8 ± 19.1
 Phosphate (mmol/L) 3.33 ± 0.49 3.26 ± 0.54 2.97 ± 0.21 3.06 ± 0.64
 ALP (U/L) 81 ± 15 74 ± 12 98 ± 24 90 ± 24
 Urea (mmol/L) 8.3 ± 1.12 8.2 ± 0.82 7.2 ± 1.4 8.1 ± 1.2
 Creatinine (µmol/L) 15.9 ± 0.9 16.2 ± 1.5 16.1 ± 1.7 17.3 ± 1.5
 Albumin (g/L) 29.5 ± 2.2 30.7 ± 0.8 32.2 ± 1.5 31.9 ± 1.9
Mean ± s.d, values are shown. Wild-type males (Sox3+/Y), mutant males (Sox3−/Y), wild-type females (Sox3+/+), and mutant carrier females (Sox3+/−). There 
were no significant differences between knockout and wild-type littermates at the same age.
ALP, alkaline phosphatase; Corr. Ca, corrected calcium; PTH, parathyroid hormone.
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activities (Sox3−/Y = 700.3 ± 183.2 U/L vs 270.2 ± 49.4 U/L, 
P < 0.001; Sox3+/−= 906.4 ± 217.2 U/L vs 282.4 ± 48.4 U/L, 
P < 0.001, n = 12–22) (Fig. 3D). Sox3−/Y and Sox3+/− mice 
on the low diet also had significantly lower plasma: 
urea concentrations (Sox3−/Y = 6.06 ± 0.92 mmol/L 
vs 7.83 ± 0.87 mmol/L, P < 0.001; and 
Sox3+/− = 5.88 ± 0.92 mmol/L vs 7.10 ± 0.74 mmol/L, 
P < 0.018, n = 13–25) (Fig. 3E); and creatinine concentrations 
(Sox3−/Y = 13.2 ± 1.3 µmol/L vs 16.8 ± 1.4 µmol/L, P < 0.001; 
and Sox3+/− = 15.3 ± 1.3 µmol/L vs 17.7 ± 1.6 µmol/L, 
P < 0.002, n = 12–23) (Fig. 3F). The plasma corrected 
calcium and PTH concentrations in Sox3−/Y and Sox3+/− 
mice on the low diet were not statistically different to the 
wild-type mice on the low diet, indicating that Sox3−/Y 
and Sox3+/− mice have normal parathyroid function (Fig. 
3B and C). Plasma ALP activities and urea and creatinine 
concentrations were also similar in wild-type mice 
compared to Sox3−/Y and Sox3+/− mice on the low calcium 
diet (Fig. 3D, E and F).
Histological analysis of parathyroid gland size from 
wild-type and mutant Sox3 mice revealed that parathyroid 
gland areas in Sox3+/Y and Sox3−/Y mice were significantly 
greater, in keeping with diet-induced secondary 
hyperparathyroidism, in mice on the low diet, when 
compared to the control diet (Sox3+/Y = 3885 ± 1012 µm2/g 
vs 1824 ± 656 µm2/g, P = 0.007; and Sox3−/Y = 4672 ± 1914 
µm2/g vs 2539 ± 684 µm2/g, P = 0.040, n = 4); however, 
there was no difference between Sox3+/Y and Sox3−/Y mice 
on each diet (normal diet P = 0.091; low diet P = 0.247) (Fig. 
3G and H). Parathyroid gland sizes in Sox3+/+ and Sox3+/− 
mice were similar on the low diet compared to the control 
diet (Sox3+/+ = 4065 ± 1178 µm2/g vs 2775 ± 1244 µm2/g, 
P = 0.091; and Sox3+/− = 4542 ± 1664 µm2/g vs 
2684 ± 1010 µm2/g, P = 0.052, n = 4), and there was no 
difference between Sox3+/+ and Sox3+/− mice on each diet 
(normal diet P = 0.457; low diet P = 0.328) (Fig. 3G). Thus, 
Sox3−/Y and Sox3+/− mice appear to have normal parathyroid 
function and normal responses to hypocalcaemia, and 
loss of Sox3 does not result in smaller parathyroids or HPT.
Mice deleted for ultraconserved element uc482 
have normal plasma calcium and 
PTH concentrations
Mice were genotyped (Fig. 4A) and wild-type (uc482+/Y) 
and hemizygous (uc482−/Y) male adult mice, and wild-
type (uc482+/+) and heterozygous (uc482+/−) female adult 
mice were found to have normal plasma biochemistry at 
the ages of 8 weeks and 28 weeks (Table 2). Thus, plasma 
corrected calcium concentrations were similar in uc482+/Y 
mice compared to uc482−/Y mice (2.95 ± 0.08 mmol/L vs 
2.98 ± 0.10 mmol/L at 8 weeks, and 2.76 ± 0.08 mmol/L 
vs 2.83 ± 0.13 mmol/L at 28 weeks, n = 10−24); and 
in uc482+/+ mice compared to uc482+/− mice 
(2.80 ± 0.07 mmol/L vs 2.84 ± 0.12 mmol/L at 8 weeks, and 
2.70 ± 0.05 mmol/L vs 2.72 ± 0.12 mmol/L at 28 weeks, 
n = 7–42) (Table 2). Plasma PTH concentrations were also 
similar in uc482+/Y and uc482−/Y mice (12.9 ± 9.3 pmol/L 
vs 12.1 ± 9.0 pmol/L at 8 weeks, and 19.9 ± 16.7 pmol/L vs 
26.7 ± 15.3 pmol/l at 28 weeks, n = 14–20); and in uc482+/+ 
and uc482+/− mice (11.1 ± 10.4 pmol/L vs 23.5 ± 24.3 pmol/L 
at 8 weeks, and 18.4 ± 20.2 pmol/L vs 13.6 ± 12.0 pmol/L 
at 28 weeks, n = 9–19) (Table 2). In addition, the plasma 
phosphate, urea, creatinine and albumin concentrations, 
and alkaline phosphatase activities were similar in wild-
type and mutant uc482 mice at 8 weeks and 28 weeks of 
age (Table 2).
When challenged with the low diet for 60 days, plasma 
corrected calcium concentrations were significantly lower 
in: male wild-type (uc482+/Y) and mutant hemizygous 
(uc482−/Y) mice (uc482+/Y = 2.01 ± 0.17 mmol/L vs 
2.95 ± 0.08 mmol/L, P < 0.0001; and uc482−/Y = 1.90 ± 0.27 
vs 2.98 ± 0.10 mmol/L, P < 0.0001, n = 10–24); and in 
female wild-type (uc482+/+) and heterozygous (uc482+/−) 
mice (uc482+/+ = 1.92 ± 0.11 mmol/L vs 2.80 ± 0.07 
mmol/L, P < 0.0001; and uc482+/− = 1.93 ± 0.17 mmol/L vs 
2.84 ± 0.12 mmol/L, P < 0.0001, n = 14-42) (Fig. 4B). These 
lower plasma corrected calcium concentrations were not due 
to lower plasma albumin concentrations when on the low 
diets, as these plasma albumin concentrations were similar 
(uc482+/+ = 30.44 ± 0.34 g/L, uc482+/- = 30.73 ± 0.26 g/L, 
uc482+/Y = 30.63 ± 0.38 g/L and uc482−/Y = 30.41 ± 0.70 g/L), 
on low diet to those observed in mice on the control diet 
(Table 2). This was associated with significantly higher 
plasma PTH concentrations in uc482+/Y and uc482−/Y mice 
(uc482+/Y = 194.6 ± 48.2 pmol/L vs 12.9 ± 9.3 pmol/L, 
P < 0.0001; and uc482−/Y = 194.0 ± 36.3 pmol/L vs 
12.1 ± 9.0 pmol/L, P < 0.0001, n = 10–20); and in uc482+/+ 
and uc482+/– mice (uc482+/+ = 211.3 ± 26.4 pmol/L vs 
11.1 ± 10.4 pmol/L, P < 0.0.0001; and uc482+/– = 
226.3 ± 54.4 pmol/L vs 23.5 ± 24.3 pmol/L, P < 0.0001, 
n = 9–19) (Fig. 4C). Plasma ALP activities were also 
significantly higher in: uc482+/Y and uc482−/Y mice 
(uc482+/Y = 1062.7 ± 233.1 U/L vs 280.7 ± 53.9 U/L, 
P < 0.0001; and uc482−/Y = 1123.0 ± 125.4 U/L vs 
279.8 ± 36.8 U/L, P < 0.0001, n = 17–29); and in uc482+/+ 
and uc482+/– mice (uc482+/+ = 1189.9 ± 211.0 U/L vs 
286.8 ± 41.1 U/L, P < 0.0001; and uc482+/− = 1133.7 ± 346.5 
U/L vs 293.8 ± 40.1 U/L, P < 0.0001, n = 13–40) (Fig. 4D). 
The plasma corrected calcium and PTH concentrations, 
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and plasma ALP activities in uc482–/Y and uc482+/– mice 
on the low diet were similar to those of the uc482+/Y and 
uc482+/+ mice, respectively, on the control diet, indicating 
that uc482−/Y and uc482+/− mice have normal parathyroid 
function (Fig. 4B, C and D). There were no differences 
in plasma urea or creatinine concentrations between 
uc482+/Y, uc482+/+, uc482−/Y or uc482+/− mice on the low 
diet compared to the control diet (Fig. 4E and F).
Histological analysis of parathyroid gland size 
from wild-type and mutant uc482 mice revealed that 
parathyroid gland areas in all genotypes were significantly 
larger, in keeping with diet-induced secondary 
hyperparathyroidism, in mice on the low diet compared 
to the control diet (uc482+/Y = 7697 ± 1596 µm2/g vs 
3545 ± 824 µm2/g, P = 0.002; uc482−/Y = 7887 ± 1016 µm2/g 
vs 3797 ± 802 µm2/g, P < 0.001; uc482+/+ = 7525 ± 1780 µm2/g 
vs 4220 ± 1348 µm2/g, P = 0.013; and uc482+/− = 
7693 ± 276 µm2/g vs 5123 ± 782 µm2/g, P = 0.004, 
n = 4) (Fig. 4G, H). There were no differences between 
uc482+/Y and uc482−/Y mice, or between uc482+/+ and 
Figure 4
Plasma biochemistry and parathyroid gland sizes 
in wild-type and mutant uc482 mice consuming 
either control or low calcium and vitamin D diets. 
(A) Genotyping of wild-type (uc482+/Y) and 
hemizygous (uc482−/Y) male, and wild-type 
(uc482+/+) and heterozygous (uc482+/−) female 
mice. S: size marker; B: blank; WT: wild-type band; 
mut: mutant band. (B) Plasma corrected calcium; 
(C) plasma PTH; (D) plasma alkaline phosphatase 
(ALP) activity; (E) plasma urea; (F) plasma 
creatinine; (G) parathyroid gland area. Wild-type 
males (+/Y) and mutant males (−/Y) are shown by 
the dark grey and light grey solid bars, 
respectively. Wild-type females (+/+) and mutant 
carrier females (+/−) are shown by the dark grey 
and light grey hatched bars, respectively. Data are 
presented as mean ± s.d. *P < 0.05; **P < 0.01; 
$P < 0.001; $$P < 0.0001 for mice on the low 
calcium and vitamin D (low Ca2+ and vit D) diet 
compared to mice of the same genotype on the 
normal diet. (H) Representative histological 
images used for quantification of parathyroid 
gland area. Pt: parathyroid; Th: thyroid; SM: strap 
muscle. Scale bars = 200 µm.
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uc482+/− mice, either on the control diet, or the low diet 
(uc482+/Y vs uc482−/Y control diet P = 0.338 and low diet 
P = 0.424; and uc482+/+ vs uc482+/− control diet P = 0.145 
and low diet P = 0.432). Thus, uc482−/Y and uc482+/− mice 
appear to have normal parathyroid gland function and 
normal responses to hypocalcaemia, and loss of uc482 
does not result in smaller parathyroids or HPT.
Discussion
The molecular and cellular effects of the interstitial 
deletion-insertion involving chromosomes Xq27.1 and 
2p25.3 in two families with XLHPT and their effects 
on SOX3 expression in the etiology of HPT remain to 
be elucidated (Fig. 1). Elucidation of the mechanism(s) 
may also have relevance to other disorders, as interstitial 
deletion-insertions involving deletions at the same locus 
on Xq27.1, but insertions from other autosomes, have 
been described in other diseases (7, 24, 25, 26) (Fig. 5). 
For example, three families with X-linked congenital 
generalized hypertrichosis (CGH) have been reported to 
have deletion-insertions comprising: a Chinese family 
with a ~1.3 kb Xq27.1 deletion and a ~125.5 kb 5q35.3 
insertion containing intronic sequence from within 
collagen type 23, alpha 1 (COL23A1); a Mexican family 
with a 7 bp deletion and a ~300 kb 4q31.22-31.23 
inverted insertion containing protein arginine 
methyltransferase 10 (PRMT10), transmembrane protein 
184C (TMEM184C), and parts of Rho GTPase activating 
protein 10 (ARHGAP10) and endothelin receptor type A 
(EDNRA); and another Mexican family with a 2 bp Xq27.1 
deletion and a ~389 kb 6p21.2 insertion containing 
Dishevelled-associated activator of morphogenesis 2 
(DAAM2) and kinesin family member 6 (KIF6) and a 
56 bp 3q21.1 insertion containing part of family with 
sequence similarity 162 member A (FAM162A) (27, 28, 29) 
(Fig. 5). There are two distinguishing clinical features in 
these CGH families. In the Chinese family, the presence 
of spina bifida in the proband and scoliosis in 4 family 
members implicates a role for SOX3, which has been 
linked to neural tube defects in man (24, 25), chicken (26), 
Drosophila (30) and zebrafish (31). In the Mexican family 
with the 6p21.2 and 3q21.1 insertions, several members 
also had dental anomalies. The disease mechanism in this 
family was postulated to be a position effect on fibroblast 
growth factor 13 (FGF13), located ~1.2 Mb proximal to 
the insertion site, and decreased expression of FGF13, 
which is found in developing hair follicles, dental 
mesenchyme and in developing tooth buds, was detected 
in patient keratinocytes (27). By contrast, a patient with 
XX male sex reversal was found to have a 4 bp deletion 
at the same locus on Xq27.1 and a ~774 kb 1q25.2-25.3 
insertion containing 6 complete genes (acyl-CoA binding 
domain containing 6 (ACBD6), xenotropic and polytropic 
retrovirus receptor 1 (XPR1), unknown gene KIAA1614, 
Table 2 Plasma biochemistry in 8 and 28 week old wild-type and mutant uc482 mice consuming the control diet.
Genotype
Males Females
uc482+/Y uc482−/Y uc482+/+ uc482+/−
Age: 8 weeks (n = 17–25) (n = 20–25) (n = 9–15) (n = 19–44)
 Body weight (g) 21.32 ± 2.53 21.62 ± 1.49 17.51 ± 1.25 17.20 ± 1.51
 Corr. Ca (mmol/L) 2.95 ± 0.08 2.98 ± 0.10 2.80 ± 0.07 2.84 ± 0.12
 PTH (pmol/L) 12.9 ± 9.3 12.1 ± 9.0 11.1 ± 10.4 23.5 ± 24.3
 Phosphate (mmol/L) 4.10 ± 0.70 4.17 ± 0.39 4.01 ± 0.54 3.95 ± 0.52
 ALP (U/L) 280.7 ± 53.9 279.8 ± 36.8 286.8 ± 41.1 293.8 ± 40.1
 Urea (mmol/L) 6.29 ± 0.80 6.16 ± 0.79 6.63 ± 1.04 6.29 ± 1.42
 Creatinine (µmol/L) 28.88 ± 2.23 28.63 ± 2.20 28.43 ± 1.55 29.05 ± 2.38
 Albumin (g/L) 29.8 ± 1.5 29.0 ± 1.3 32.0 ± 1.9 31.7 ± 1.5
Age: 28 weeks (n = 8–14) (n = 10–16) (n = 11–15) (n = 8–12)
 Body weight (g) 37.13 ± 4.94 37.79 ± 5.28 27.07 ± 4.93 26.14 ± 4.28
 Corr. Ca (mmol/L) 2.76 ± 0.08 2.83 ± 0.13 2.70 ± 0.05 2.72 ± 0.12
 PTH (pmol/L) 19.9 ± 16.7 26.7 ± 15.3 18.4 ± 20.2 13.6 ± 12.0
 Phosphate (mmol/L) 3.55 ± 0.55 3.71 ± 0.66 3.20 ± 0.54 3.42 ± 0.51
 ALP (U/L) 69.7 ± 7.5 71.0 ± 7.0 79.7 ± 8.5 85.3 ± 18.8
 Urea (mmol/L) 10.04 ± 1.04 9.23 ± 1.21 8.46 ± 0.83 8.73 ± 1.18
 Creatinine (µmol/L) 33.8 ± 2.2 35.3 ± 2.2 33.4 ± 1.7 34.3 ± 3.0
 Albumin (g/L) 30.5 ± 1.3 31.1 ± 1.3 31.5 ± 1.8 31.8 ± 1.6
Mean ± s.d. values are shown. Wild-type males (uc482+/Y), mutant males (uc482−/Y), wild-type females (uc482+/+) and mutant carrier females (uc482+/−). 
There were no significant differences between knock-out and wild-type littermates at the same age.
ALP, alkaline phosphatase; Corr. Ca, corrected calcium; PTH, parathyroid hormone.
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syntaxin 6 (STX6), ovarian adenocarcinoma amplified 
long ncRNA (OVAAL), and microRNA 3121 (MIR3121)) 
and two partial genes (LIM homeobox 4 (LHX4) and 
major histocompatibility complex, class-I related (MR1)), 
that switched on SOX3 expression in lymphoblastoid cells 
from the patient but did not affect FGF13 expression (12) 
(Fig. 5). Combined, these studies demonstrate that diverse 
phenotypes can result from similar sized insertions into 
the same Xq27.1 locus, and that similar phenotypes 
(e.g. CGH) can result from insertions from different 
autosomes, highlighting the complexity underlying long-
range gene regulation and the effects of chromosomal 
rearrangements in disease. Indeed, Hi-C chromatin 
interaction analyses have revealed that the alterations of 
genomic repressors or enhancers can affect long-range 
gene expression, and thus it is feasible that these deletion-
insertions of Xq27.1 may affect genes that are nearby 
SOX3, but which exert their effects on different distant 
genes. For example, MIR505 located downstream of SOX3 
(Figs 1 and 5) encodes a microRNA that inhibits: neural 
tube formation by targeting fibroblast growth factor 18 
(FGF18) located on chromosome 5q35.1 (32); and cell 
growth and endothelial migration by targeting mitogen-
activated protein kinase kinase kinase 3 (MAP3K3) 
through the AKT-NF-κB pathway whose genes are located 
on chromosomes 17q23.3 (MAP3K3), 14q32.33 (AKT 
serine/threonine kinase 1 (AKT)), 10q24.31 (component 
of inhibitor of nuclear factor kappa B kinase complex 
(IKK1)), 8p11.21 (inhibitor of nuclear factor kappa B 
kinase subunit beta (IKK2)), 4q24 (nuclear factor kappa b 
subunit 1 (NFKB1)), and 11q13.1 (RELA proto-oncogene, 
NF-KB subunit (RELA)) (33). Thus, altered expression of 
MIR505 could be involved in the occurrence of spina 
bifida in the proband from the Chinese family with CGH 
that is associated with a deletion of Xq27.1 and insertion 
of 5q35.3 (29), although it also remains possible that it is 
the deletion-insertion associated disruption of SOX3 itself 
that is responsible for spina bifida, as SOX3 dysfunction 
has been reported to be linked to neural tube defects in 
human (24, 25). Different mechanisms are likely to be 
involved in the phenotypes of the other CGH families 
with insertions of 4q31.22-31.23 and 6p21.2 (27, 28), 
and the XX male sex reversal patient, with insertion of 
1q25.2-25.3, who did not have neural tube defects (12). 
Thus, it seems that different types of insertions in the same 
locus can affect expression in other genes and thereby 
result in different phenotypes. Plasma biochemistry 
has not been reported in CGH or XX male sex reversal, 
and thus any co-occurrence of HPT and associated 
hypocalcaemia in these patients remains unknown, 
although such occurrence of HPT in these patients would 
seem unlikely as hypocalcaemic seizures are likely to have 
been recognized and also as XLHPT patients do not have 
hypertrichosis or XX male sex reversal.
In the two XLHPT families, the two deletions within 
Xq27.1 are of different sizes but do overlap, whilst the 
two insertions which both originate from 2p25.3 do 
not overlap, and both deletion-insertions lead to a net 
gain of DNA of differing amounts (~315 kb and ~46 
kb), resulting in the same phenotype. This comparison 
may help to elucidate the mechanism(s) by which the 
deletion-insertion alters SOX3 expression (Fig. 1B). First, 
this may be due to loss of an enhancer or repressor from 
the shared missing segment of the X chromosome. 
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Figure 5
Chromosomal rearrangements associated with XX sex reversal and 
hypertrichosis. A patient with XX sex reversal was found to have an 
interstitial deletion-insertion involving chromosome Xq27.1 and 
chromosome 1q25.3 (11). One family from China and two unrelated 
families from Mexico with hypertrichosis have been reported to have 
interstitial deletion-insertions involving chromosome Xq27.1 and 
chromosomes 5q35.3, 4q31, and 6p21.2, respectively (23, 24, 25). Dotted 
lines denote the location of the XLHPT interstitial deletion-insertions.
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This is possible because there is overlap such that the 1.5 
kb deletion in the IL family is contained within the 25 kb 
deletion from the MO family, but unlikely because the 
small 1.5 kb region does not contain any ultraconserved 
sequences. Second, this may be due to gain of an 
enhancer or repressor within the inserted DNA. This is 
possible because most of the inserted DNA is non-coding, 
but unlikely because the two inserted regions in the two 
families do not overlap, and there is a low probability 
that two different insertions would both result in the 
same subtle effect on timing of SOX3 expression in the 
developing parathyroid glands, as is postulated in these 
two families. Third, the deletion-insertion may move an 
enhancer or repressor away from SOX3. This is possible 
because both deletion-insertions cause net gain of DNA. 
One such regulatory element, which has been shown to 
be a likely enhancer of gene expression in zebrafish, is 
uc482 (16), although uc482 has not been shown directly 
to affect SOX3 expression and our studies reveal that 
mice lacking uc482 do not develop HPT (Fig. 4 and 
Table 2). However, there are also 4 other ultraconserved 
elements in the region between SOX3 and uc482, all of 
which would also be affected by the interstitial deletion-
insertions (16), so a combinatorial loss of these elements 
may be required to alter SOX3 expression and cause HPT. 
Finally, the deletion-insertion may disrupt a topological 
associated domain (TAD), which represents a fundamental 
three-dimensional evolutionarily conserved genomic 
structural unit that directs regulatory elements to their 
promoters and insulates them from other genes (34, 35). 
Examination for the locations of TAD boundaries on the X 
chromosome in human non-parathyroid cell types using 
Hi-C chromatin interaction data did not identify TAD 
boundaries between the SOX3 and ATP11C genes, with 
the nearest TAD boundary being located approximately 
135 kb upstream of SOX3 (36). It is therefore unlikely 
that the deletion/insertion involving chromosomes 
Xq27.1 and 2p25.3 altered an existing TAD boundary 
on the X chromosome, although the possibility that the 
inserted chromatin may have resulted in the generation 
of a new TAD boundary to alter SOX3 expression cannot 
be excluded.
SOX3 expression was not altered by the Xq27.1/2p25.3 
deletion-insertion in EBV-lymphoblastoid cells from 
our XLHPT patients (Fig. 2), and this may or may not 
reflect the situation in developing parathyroid cells. 
However, absence of Sox3 expression that would occur in 
parathyroids of mutant mice with deletion of Sox3 did not 
result in hypocalcemia or HPT in Sox3-/Y mice (Fig. 3 and 
Table 1). Thus, this result indicates that complete loss of 
Sox3 expression is unlikely to cause HPT, and that XLHPT 
is likely to be due to a more complex mechanism.
Nevertheless, a role for SOX3 in parathyroid 
development is highly likely as Sox3 expression has 
been detected in developing mouse parathyroid glands 
between E10.5 and E15.5 (8). However, the absence of 
any decrease in parathyroid size or development of HPT 
in mice lacking Sox3, even when challenged with a low 
calcium diet lacking vitamin D, indicates that loss of 
Sox3 alone is not sufficient to cause HPT and that other 
SOX family transcription factors may compensate for 
loss of SOX3. Indeed, SOX proteins, which are arranged 
into groups designated A-H, compensate for each other 
within the same group. For example, two members of 
the SOXF group, SOX17 and SOX18, compensate for 
each other in developing vascular endothelial cells (37). 
SOX3 is a member of the SOXB1 group, which also 
includes SOX1 and SOX2, and all three members share 
significant protein sequence homology, which is at its 
greatest (~95%) within the high mobility group (HMG) 
DNA-binding domain (38). Furthermore, these SOXB1 
members have overlapping expression patterns in the 
CNS (38), and despite expression of Sox3 throughout 
the developing CNS, Sox3 null mice develop specific 
defects only in the hippocampus, corpus callosum and 
hypothalamus, and it is therefore postulated that partial 
compensation by SOX1 and/or SOX2 may prevent a more 
severe neurological phenotype in Sox3 null mice (19, 39). 
Indeed, redundancy between SOX2 and SOX3 has been 
shown for morphogenesis of the second pharyngeal arch 
during development in mice (39). The related SOXB1 
factor, SOX19B, also acts redundantly with SOX3 in 
restricting WNT signalling to the organiser during CNS 
development and dorsoventral patterning (40).
The absence of HPT in Sox3−/Y and Sox3+/− mice 
indicates that loss of Sox3 expression is not the underlying 
mechanism in XLHPT. Altered expression of Sox3 in three 
other ways could potentially be considered as possible 
mechanisms for XLHPT. First, the deletion-insertions 
may result in Sox3 overexpression. However, this seems 
unlikely, as patients with SOX3 duplications have been 
reported to have hypopituitarism, mental retardation, 
and XX male sex reversal, which are not features of 
XLHPT (24, 41, 42). The other two possible mechanisms 
are that Sox3 could either be expressed inappropriately 
early in the developing pharyngeal pouches, or that there 
might be inappropriate continued expression after the 
window in which Sox3 would normally be expressed. 
Sox3 expression in the mouse is detected in developing 
parathyroid glands at E10.5, E13.5, and E15.5, but not 
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at E18.5, indicating that the timing of Sox3 expression 
is likely to be important, as has been shown for other 
SOX proteins during organogenesis. For example, SRY 
expression in somatic cells of the male genital ridge has 
a critical expression window of only ~6 hours, during 
which its expression must reach a certain threshold level 
to trigger Sertoli cell differentiation (43). Consistent 
with this hypothesis, we could not demonstrate altered 
SOX3 expression in lymphoblastoid cells from XLHPT 
patients, which might not be representative of SOX3 
time and/or tissue specific expression, as for example in 
the parathyroid glands. Investigation of a temporospatial 
effect on SOX3 expression in developing parathyroid 
glands is not possible in XLHPT patients, and will require 
a mouse model engineered to harbour the appropriate 
chromosomal rearrangements.
The lower plasma urea and creatinine concentrations 
in the wild-type and mutant Sox3 mice, which are on a 
MF1 outbred background when on the low calcium and 
vitamin D diet (low diet) is interesting and likely to be 
a strain specific response to this dietary challenge. Thus, 
the plasma urea and creatinine concentrations did not 
decrease in response to the challenge with the low calcium 
and vitamin D diet, in the wild-type and mutant uc482 
mice (Fig. 4E and F), which are on a C57Bl/6 background, 
and in previously reported wild-type and mutant Gata3 
mice, which were on a FVB/N background, (21). The 
findings of a decreased plasma urea and creatinine 
concentrations in both wild-type and mutant Sox3 mice, 
but not in wild-type or mutant uc482 and Gata3 mice, 
indicate that these decreased plasma concentrations are 
not mutant dependent, but instead are strain-specific 
and may involve modifier genes that influence urea 
and creatinine metabolism. In addition, the observed 
changes in creatinine metabolism due to low vitamin D 
in the MF1 strain (Fig. 3) are similar to that reported in 
healthy populations (without chronic kidney diseases) 
from Taiwan and Spain, in whom low dietary vitamin 
D was found to correlate with low plasma creatinine 
concentrations (44, 45).
In conclusion, XLHPT does not result from the 
absence of expression of SOX3 or absence of the 
regulatory element uc482. Instead, the interstitial 
deletion-insertions likely have other effects on the 
temporospatial expression of SOX3 in the developing 
parathyroid glands.
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